Skip to main content
. 2020 Jul 16;12:1758835920937612. doi: 10.1177/1758835920937612

Figure 3.

Figure 3.

Comparison of the ORRs between patients that were PD-L1 positive (blue) and patients that were PD-L1 negative (red) in PD-1 or PD-L1 blockade monotherapy.

CI, confidence interval; GC/GEJC, gastric or gastro-esophageal junction cancer; ORR, objective response rate; PD-1, programmed cell death 1; PD-L1, programmed death-ligand 1.